In patients with early diabetic CKD, sevelamer carbonate significantly reduces HbA1c, fibroblast growth factor 23, lipids, tumor necrosis factor-α, and oxidative stress compared with CC [51]. The gene discussed is FGF23; the disease is chronic kidney disease.